It is a pharma private limited company based in Hindupur, Andhra Pradesh, India, established in 2016.
2016 | Hindupur, Andhra Pradesh, India | ActiveSriphal Life Sciences Private Limited, a active private limited company, was established on 17 February 2016 in Hindupur, Andhra Pradesh, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U24100AP2016PTC098348. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹3.56 Cr and a paid-up capital of ₹3.56 Cr.
It upholds a compliant status. Its leadership includes Venkata Satyanrayana Murthy Mella (Director), Anand Nazmal Kanekanti (Director), Koganti Sreenivasa Rao (Director). Past directors included Gurijala Chandra Mohanreddy, Uttam Sukeshchandra Roy. It holds ₹3.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5/69, H No: 21-8-243, Teachers Colony, Hindupur, Hindupur, Andhra Pradesh, 515201.
U24100AP2016PTC098348
098348
17 February 2016
₹3.56 Cr
₹3.56 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Sriphal Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Satyanrayana Murthy Mella | Director | 17 Feb 2016 | Current |
| Anand Nazmal Kanekanti | Director | 17 Feb 2016 | Current |
| Koganti Sreenivasa Rao | Director | 17 Feb 2016 | Current |
| Surya Bhaskar Rao Nistala | Additional Director | 21 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 03 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 21 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sriphal Life Sciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Sriphal Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2025 | State Bank Of India | ₹3.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sriphal Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sriphal Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriphal Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with State Bank Of India amounted to Rs. 3.50 Cr with Charge ID 101075744 was registered on 28 Feb 2025. was documented.
The activity Sriphal Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Sriphal Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was completed.
Surya Bhaskar Rao Nistala was appointed as a Additional Director was appointed as a Additional Director on 21 Jun 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
Venkata Satyanrayana Murthy Mella was appointed as a Director was appointed as a Director on 17 Feb 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.
The activity Anand Nazmal Kanekanti was appointed as a Director was appointed as a Director on 17 Feb 2016 & has been associated with this company since 9 years 9 months . was completed.
The CIN of Sriphal Life Sciences Private Limited is U24100AP2016PTC098348.
Sriphal Life Sciences Private Limited is headquartered at 5/69, H No: 21-8-243, Teachers Colony, Hindupur, Hindupur, Andhra Pradesh, 515201.
Sriphal Life Sciences Private Limited was incorporated on 17 February 2016.
The current directors of Sriphal Life Sciences Private Limited are
The primary industry of Sriphal Life Sciences Private Limited is Pharma.
Sriphal Life Sciences Private Limited is unlisted.
The authorized capital of Sriphal Life Sciences Private Limited is ₹3.56 Cr, and the paid-up capital is ₹3.56 Cr.
The compliance status of Sriphal Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX